SecBot SecBot
DEFA14A ·Filed Mar 27, 2026

RVP

RETRACTABLE TECHNOLOGIES INC
NEUTRAL
Impact 2/10
Horizonimmediate Processed7mo ago SEC0001104659-26-036051
Proxy solicitation materials
Actionable Insight • Neutral

This is a standard, uncontested director election. Traders should expect no market-moving impact from this filing. Monitor for any unexpected developments in the company's future filings or news.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
RVP ▲ +5.40% at T+60d
NEUTRAL call +5.40% · α vs SPY -10.66% · entry $0.6700 → $0.7062
Entry = T+0 close
Mar 27, 2026
via day close
T+1d
+2.99%
call +2.99% · α +3.34%
$0.6900
settled 7mo ago
T+5d
+5.97%
call +5.97% · α +2.11%
$0.7100
settled 7mo ago
T+20d
-4.48%
call -4.48% · α -17.22%
$0.6400
settled 6mo ago
T+60d
+5.40%
call +5.40% · α -10.66%
$0.7062
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Retractable Technologies, Inc. (RVP) is holding its 2026 Annual Meeting on May 8, 2026. The primary purpose of this filing is to solicit votes for the election of three Class 2 directors: Thomas J. Shaw, Walter O. Bigby, Jr., and John W. Fort III. This is a routine, management-led proxy statement with no contested issues or activist involvement.

Key Financial Metrics

Vote
director election
Meeting
2026-05-08
Seats Contested
0

Key Facts

  • The filing is a definitive proxy statement (DEFA14A) for the 2026 Annual Meeting.
  • The meeting will be held virtually on May 8, 2026.
  • The only voting item is the election of three Class 2 directors, all of whom are nominees supported by the board.
  • The filing is routine and does not contain any financial data, merger proposals, or shareholder activism.

Financial Impact

No direct financial impact is disclosed in this filing.

Risk Factors

  • The filing contains no new information that would alter an investment thesis.

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001104659-26-036051
Document: 0001104659-26-036051-index-headers.html0001104659-26-036051
Document: 0001104659-26-036051-index.html0001104659-26-036051
Document: 0001104659-26-036051.txt0001104659-26-036051
4 reports for RVP
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for RVP — sortable, filterable
TypeNow
Sep 30, 2026
27d ago
8-K
NEUTRAL ★ 2/10
$0.6900awaiting T+20—$0.5900 (−14.49%)
Aug 14, 2026
10w ago
8-K
BEARISH ★ 6/10
$0.7000 $0.6800▲ +2.86%▲ +0.88%$0.5900 (+15.71%)
Jun 30, 2026
17w ago
8-K
NEUTRAL ★ 2/10
$0.7200 $0.6702▼ −6.92%▼ −5.89%$0.5900 (−18.06%)
Mar 27, 2026
30w ago
DEFA14A
NEUTRAL ★ 2/10
$0.6700 $0.6400▼ −4.48%▼ −17.22%$0.5900 (−11.94%)
Showing 4 of 4

US Market Status

Market Closed — Opens Thu (11h 33m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 27, 2026